Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan
| Autor: | Zakarya, Kunsulu a, Kutumbetov, Lespek a, Orynbayev, Mukhit a, Abduraimov, Yergali a, Sultankulova, Kulyaisan a, Kassenov, Markhabat a, Sarsenbayeva, Gulbanu a, Kulmagambetov, Ilyas b, Davlyatshin, Timur c, Sergeeva, Maria d, Stukova, Marina d, Khairullin, Berik a, ⁎ |
|---|---|
| Zdroj: | In EClinicalMedicine September 2021 39 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|